National Bureau of Statistics. Final Statistical Monitoring Report of the China Women’s Development Program (2011–2020). China Information News.

Paschou SA, Anagnostis P, Pavlou DI, Vryonidou A, Goulis DG, Lambrinoudaki I. Diabetes in menopause: risks and management. Curr Vasc Pharmacol. 2019;17(6):556–63. https://doi.org/10.2174/1570161116666180625124405.

Article  CAS  PubMed  Google Scholar 

Ren Y, Zhang M, Liu Y, et al. Association of menopause and type 2 diabetes mellitus. Menopause. 2019;26(3):325–30. https://doi.org/10.1097/GME.0000000000001200.

Article  PubMed  Google Scholar 

Dmytriw AA, Hui N, Singh T, et al. Bibliometric evaluation of systematic review and meta analyses published in the top 5 “high-impact” radiology journals. Clin Imaging. 2021;71:52–62. https://doi.org/10.1016/j.clinimag.2020.11.008.

Article  PubMed  Google Scholar 

Azer SA, Azer S. Top-cited articles in medical professionalism: a bibliometric analysis versus altmetric scores. BMJ Open. 2019;9(7): e029433. https://doi.org/10.1136/bmjopen-2019-029433.

Article  PubMed  PubMed Central  Google Scholar 

Liu C, Yuan Q, Mao Z, et al. The top 100 most cited articles on rhabdomyolysis: a bibliometric analysis. Am J Emerg Med. 2020;38(9):1754–9. https://doi.org/10.1016/j.ajem.2020.05.031.

Article  PubMed  Google Scholar 

Portman DJ, Gass MLS. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063–8. https://doi.org/10.1097/GME.0000000000000329.

Article  PubMed  Google Scholar 

Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med. 2009;6(8):2133–42. https://doi.org/10.1111/j.1743-6109.2009.01335.x.

Article  PubMed  Google Scholar 

Faubion SS, Sood R, Kapoor E. Genitourinary syndrome of menopause: management strategies for the clinician. Mayo Clin Proc. 2017;92(12):1842–9. https://doi.org/10.1016/j.mayocp.2017.08.019.

Article  PubMed  Google Scholar 

Alvisi S, Gava G, Orsili I, et al. Vaginal health in menopausal women. Medicina (Kaunas). 2019;55(10):615. https://doi.org/10.3390/medicina55100615.

Article  PubMed  Google Scholar 

Kingsberg SA, Krychman M, Graham S, Bernick B, Mirkin S. The women’s EMPOWER survey: identifying women’s perceptions on vulvar and vaginal atrophy and its treatment. J Sex Med. 2017;14(3):413–24. https://doi.org/10.1016/j.jsxm.2017.01.010.

Article  PubMed  Google Scholar 

Palma F, Volpe A, Villa P, Cagnacci A. Writing group of AGATA study. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study. Maturitas. 2016;83:40–4. https://doi.org/10.1016/j.maturitas.2015.09.001.

Article  CAS  PubMed  Google Scholar 

Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women’s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med. 2013;10(7):1790–9. https://doi.org/10.1111/jsm.12190.

Article  PubMed  Google Scholar 

Salvatore S, Nappi RE, Parma M, et al. Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy. Climacteric. 2015;18(2):219–25. https://doi.org/10.3109/13697137.2014.975197.

Article  CAS  PubMed  Google Scholar 

Salvatore S, Nappi RE, Zerbinati N, et al. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014;17(4):363–9. https://doi.org/10.3109/13697137.2014.899347.

Article  CAS  PubMed  Google Scholar 

Salvatore S, Leone Roberti Maggiore U, Athanasiou S, et al. Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study. Menopause. 2015;22(8):845–9. https://doi.org/10.1097/GME.0000000000000401.

Article  PubMed  Google Scholar 

Gambacciani M, Levancini M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric. 2015;18(5):757–63. https://doi.org/10.3109/13697137.2015.1045485.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaspar A, Brandi H, Gomez V, Luque D. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med. 2017;49(2):160–8. https://doi.org/10.1002/lsm.22569.

Article  PubMed  Google Scholar 

Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 2012;345: e6409. https://doi.org/10.1136/bmj.e6409.

Article  CAS  PubMed  Google Scholar 

Ren M, Ruan X, Gu L, Pexman-Fieth C, Kahler E, Yu Q. Ultra-low-dose estradiol and dydrogesterone: a phase III study for vasomotor symptoms in China. Climacteric. 2022;25(3):286–92. https://doi.org/10.1080/13697137.2021.1956894.

Article  CAS  PubMed  Google Scholar 

Xu Z, Chung HF, Dobson AJ, Wilson LF, Hickey M, Mishra GD. Menopause, hysterectomy, menopausal hormone therapy and cause-specific mortality: cohort study of UK Biobank participants. Hum Reprod. 2022;37(9):2175–85. https://doi.org/10.1093/humrep/deac137.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu Q, Chae HD, Hsiao SM, et al. Prevalence, severity, and associated factors in women in East Asia with moderate-to-severe vasomotor symptoms associated with menopause. Menopause. 2022;29(5):553–63. https://doi.org/10.1097/GME.0000000000001949.

Article  PubMed  PubMed Central  Google Scholar 

Blanken A, Gibson CJ, Li Y, et al. Racial/ethnic disparities in the diagnosis and management of menopause symptoms among midlife women veterans. Menopause. 2022;29(7):877–82. https://doi.org/10.1097/GME.0000000000001978.

Article  PubMed  PubMed Central  Google Scholar 

Pershad A, Morris JM, Pace D, Khanna P. Racial disparities in menopausal hormone therapy acceptance: a pilot study. Menopause. 2022;29(11):1263–8. https://doi.org/10.1097/GME.0000000000002061.

Article  PubMed  Google Scholar 

Heinig M, Braitmaier M, Haug U. Prescribing of menopausal hormone therapy in Germany: current status and changes between 2004 and 2016. Pharmacoepidemiol Drug Saf. 2021;30(4):462–71. https://doi.org/10.1002/pds.5186.

Article  PubMed  Google Scholar 

Park CY, Lim JY, Kim WH, Kim SY, Park HY. Evaluation of menopausal hormone therapy use in Korea (2002–2013): a nationwide cohort study. Maturitas. 2021;146:57–62. https://doi.org/10.1016/j.maturitas.2021.02.003.

Article  CAS  PubMed  Google Scholar 

Ott J, Egarter C, Aguilera A. Dydrogesterone after 60 years: a glance at the safety profile. Gynecol Endocrinol. 2022;38(4):279–87. https://doi.org/10.1080/09513590.2021.2016692.

Article  PubMed  Google Scholar 

Chlebowski RT, Anderson GL. Menopausal hormone therapy and cancer: changing clinical observations of target site specificity. Steroids. 2014;90:53–9. https://doi.org/10.1016/j.steroids.2014.06.001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prentice RL, Aragaki AK, Chlebowski RT, et al. Randomized trial evaluation of the benefits and risks of menopausal hormone therapy among women 50–59 years of age. Am J Epidemiol. 2021;190(3):365–75. https://doi.org/10.1093/aje/kwaa210.

Article  PubMed  Google Scholar 

Graham S, Archer DF, Simon JA, Ohleth KM, Bernick B. Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins. Gynecol Endocrinol. 2022;38(11):891–910. https://doi.org/10.1080/09513590.2022.2118254.

Article  CAS  PubMed  Google Scholar 

Liu JH. The role of progestogens in menopausal hormone therapy. Clin Obstet Gynecol. 2021;64(4):772–83. https://doi.org/10.1097/GRF.0000000000000657.

Article  PubMed  Google Scholar 

Perkins MS, Louw-du Toit R, Jackson H, Simons M, Africander D. Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha. Front Endocrinol (Lausanne). 2022;13: 959396. https://doi.org/10.3389/fendo.2022.959396.

Article  PubMed  Google Scholar 

Nappi RE, Simoncini T. Menopause transition: a golden age to prevent cardiovascular disease. Lancet Diabetes Endocrinol. 2021;9(3):135–7. https://doi.org/10.1016/S2213-8587(21)00018-8.

Article  PubMed  Google Scholar 

Aryan L, Younessi D, Zargari M, et al. The role of estrogen receptors in cardiovascular disease. Int J Mol Sci. 2020;21(12):4314. https://doi.org/10.3390/ijms21124314.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharad P, Agarwal N, Chopra S, et al. Assessment of endothelial dysfunction by brachial artery flow-mediated dilatation in postmenopausal women at low risk for cardiovascular disease. J Midlife Health. 2021;12(3):193–8. https://doi.org/10.4103/jmh.jmh_111_21.

Article  PubMed  PubMed Central